JCOVDEN™ Covid 19 Vaccine Ad26.COV2 S recombinant

Janssen’s COVID-19 Vaccine Global Information

eAwaz Medicine

London – The authorization or approval status of Janssen’s Covid-19 vaccine varies by country. Unless approved or licensed by the relevant health authority, the product is investigational and its safety and efficacy have not been established. JCOVDEN™ (Covid-19 Vaccine (Ad26.COV2-S [recombinant])) is indicated for active immunization for the prevention of coronavirus disease-2019 (Covid-19) caused by SARS-CoV-2 virus in individuals 18 …